bifidobacterium breve M-16V
Identification
| Name | bifidobacterium breve M-16V |
Regulatory
| FDA/DG SANTE Petitions, Reviews, Notices | GRN 455 |
Physical Properties
| Food Chemicals Codex Listed | No |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | food additive |
| Recommendation for bifidobacterium breve M-16V usage levels up to | not for fragrance use. |
| Recommendation for bifidobacterium breve M-16V flavor usage levels up to | not for flavor use. |
Chemical sources Association Inc
Exchange of knowledge
Need This Item for Flavor? You can contact the Chemical Sources Association.
Potential Uses
Natural Occurrence
Synonyms
bifidobacterium breve M-16V
PubMed:
The development of allergic inflammation in a murine house dust mite asthma model is suppressed by synbiotic mixtures of non-digestible oligosaccharides and Bifidobacterium breve M-16V.
PubMed:
Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates--a randomised double blind placebo controlled trial.
PubMed:
No detectable beneficial systemic immunomodulatory effects of a specific synbiotic mixture in infants with atopic dermatitis.
PubMed:
Bifidobacterium breve alters immune function and ameliorates DSS-induced inflammation in weanling rats.
PubMed:
Bifidobacterium breve prevents necrotising enterocolitis by suppressing inflammatory responses in a preterm rat model.
PubMed:
Synbiotics-supplemented amino acid-based formula supports adequate growth in cow's milk allergic infants.
PubMed:
Novel immunotherapy approaches to food allergy.
PubMed:
Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota.
PubMed:
Galectin-9 induced by dietary synbiotics is involved in suppression of allergic symptoms in mice and humans.
PubMed:
Effect of administration of bifidobacteria on intestinal microbiota in low-birth-weight infants and transition of administered bifidobacteria: a comparison between one-species and three-species administration.
PubMed:
Intestinal epithelium-derived galectin-9 is involved in the immunomodulating effects of nondigestible oligosaccharides.
PubMed:
Effects of Bifidobacterium breve on inflammatory gene expression in neonatal and weaning rat intestine.
PubMed:
Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis.
PubMed:
Synbiotics reduce allergen-induced T-helper 2 response and improve peak expiratory flow in allergic asthmatics.
PubMed:
Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial.
PubMed:
Safety evaluation of probiotic bifidobacteria by analysis of mucin degradation activity and translocation ability.
PubMed:
Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: a bacterial strain comparative study.
PubMed:
Cow milk allergy symptoms are reduced in mice fed dietary synbiotics during oral sensitization with whey.
PubMed:
Suppressive effects of bifidobacterium breve strain M-16V on T-helper type 2 immune responses in a murine model.
PubMed:
[Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis].
PubMed:
Effects of oral administration of bifidobacterium breve on fecal lactic acid and short-chain fatty acids in low birth weight infants.